Investigational Site Number : 1580002

Taoyuan City 333

2 studies enrolling now · 2 studies all time

What they study most

Immunoglobulin G4 Related Disease, Pruritus

Studies at this site

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — Recruiting now
• Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC) — Recruiting now